Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... [Yahoo! Finance]
Zomedica Corp. Common Shares (ZOM)
US:NYSE Investor Relations:
investors.zomedica.com
Company Research
Source: Yahoo! Finance
Diagnostics Segment Revenue: Approximately $500,000, an increase of 38%. Gross Margin: 72.3%, higher than last year's 69%. Operating Expenses: $12.5 million, an increase of 21% year-over-year. Net Loss: $6.7 million, or 0.007 cents per share. Non-GAAP EBITDA Loss: $4.8 million. Cash and Equivalents: $77.8 million at the end of the quarter. Cash Used in Quarter: Approximately $5.1 million. Warning! GuruFocus has detected 1 Warning Sign with ZOM. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Zomedica Corp ( ZOM ) reported a strong third quarter with double-digit top-line growth and solid gross margins. The company achieved a new revenue record for the third quarter at $7 million, reflecting over 10% growth year-over-year. Zomedica Corp ( ZOM ) has expanded its global reach through strategic partnerships with distributors in new international markets, enhancing growth opportunit
Show less
Read more
Impact Snapshot
Event Time:
ZOM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZOM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZOM alerts
High impacting Zomedica Corp. Common Shares news events
Weekly update
A roundup of the hottest topics
ZOM
News
- Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial OfficerAccesswire
- Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 [Yahoo! Finance]Yahoo! Finance
- Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024Accesswire
- Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform [Yahoo! Finance]Yahoo! Finance
ZOM
Sec Filings
- 12/19/24 - Form 8-K
- 11/26/24 - Form 4/A
- 11/19/24 - Form 8-K
- ZOM's page on the SEC website